Home > Publications database > Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial.
 
Journal Article (Letter) DKFZ-2025-01796
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
John Wiley & Sons Ltd. Hoboken

HemaSphere 9(8), e70205 () [10.1002/hem3.70205]
 GO

Classification:
Contributing Institute(s):
  1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database
 Record created 2025-08-28, last modified 2025-09-01
Similar records


Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio 1.1.7-dirty
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy